Overview Phase 2 Study of KLS-0611 in Patients With Dry Eye Syndromes Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary To evaluate the efficacy and safety of KLS-0611 compared to placebo in patients with dry eye syndromes. Phase: Phase 2 Details Lead Sponsor: Kissei Pharmaceutical Co., Ltd.